LGT Group Foundation’s West Pharmaceutical WST Stock Holding History

LGT Group Foundation’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$80.2M	Buy	223,365 +19,809	+10%	+$6.06M	0.91%	27
2026 Q1	$51M	Sell	203,556 -1,531	-0.7%	-$381K	0.62%	35
2025 Q4	$56.8M	Sell	205,087 -4,498	-2%	-$1.23M	0.62%	36
2025 Q3	$56.9M	Sell	209,585 -14,341	-6%	-$3.49M	0.65%	34
2025 Q2	$49M	Buy	223,926 +2,885	+1%	+$617K	0.61%	36
2025 Q1	$49.5M	Buy	221,041 +113,917	+106%	+$31.4M	0.68%	34
2024 Q4	$35.1M	Sell	107,124 -249	-0.2%	-$78.4K	0.54%	44
2024 Q3	$32.2M	Sell	107,373 -101,661	-49%	-$31.1M	0.53%	45
2024 Q2	$68.9M	Buy	+209,034	New	+$73.9M	1.09%	23

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

LGT Group Foundation's WST Position: Q2 2026 in Review

LGT Group Foundation increased its West Pharmaceutical (WST) stake by 9.7% in Q2 2026, buying an estimated $6.06M and bringing the position to 223,365 shares worth $80.2M. The position accounts for 0.91% of the portfolio, ranked #27.

LGT Group Foundation first reported a position in WST in Q2 2024 and has held it in 9 quarters since. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

LGT Group Foundation held 223,365 shares of West Pharmaceutical worth $80.2M as of Q2 2026.
LGT Group Foundation bought 19,809 West Pharmaceutical shares in Q2 2026, an estimated $6.06M.
West Pharmaceutical made up 0.91% of LGT Group Foundation's portfolio in Q2 2026, its #27 holding.
LGT Group Foundation first reported a position in West Pharmaceutical in Q2 2024 and has held it in 9 quarters since.
831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on LGT Group Foundation's 13F filing for Q2 2026, filed 10 Aug 2026.